News
EU backs approval of Moderna’s COVID-19 vaccine in 12-17 year-olds
Moderna’s COVID-19 vaccine has received a positive opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) for use in adolescents aged 12 to 17 years of age.